Pillstats
Rx only · Injection, Solution · Intravenous

Irinotecan Hydrochloride

Brands: Camptosar · Irinotecan Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01CE02
RxCUI (US)51499
US makers8 labelers
Packages23
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.2K4.4K6.6K8.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.9K
Rx · 2026 Q1
47K
Units dispensed
-48%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pharmacia & Upjohn Company LLCunknown4SUPPLYING
Eugia US LLCunknown4SUPPLYING
Apotex Corp.unknown3SUPPLYING
Hospira, Inc.unknown3SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown3SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2EXITED 2026
Actavis Pharma, Inc.unknown2EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 26, 2025
    RESOLVEDShortage resolved: Irinotecan Hydrochloride Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Irinotecan Hydrochloride Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Oncology.

  • Sep 26, 2025
    SHORTAGEDrug shortage: Irinotecan Hydrochloride Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Irinotecan Hydrochloride Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Oncology.

  • Aug 4, 2025
    RESOLVEDShortage resolved: Irinotecan Hydrochloride Injection (Teva Pharmaceuticals USA, Inc.)

    Irinotecan Hydrochloride Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.

  • Aug 4, 2025
    SHORTAGEDrug shortage: Irinotecan Hydrochloride Injection (Teva Pharmaceuticals USA, Inc.)

    Irinotecan Hydrochloride Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.